COMPANY

Biological Mimetics

HQ: Frederick, MD source · biologicalmimetics.com ↗ · Mid-Atlantic

Keywords: From press sources:vaccine infectious disease diagnostics

Location: Frederick, MD · source · Oct 14, 2026

Profile checked Oct 10, 2026

35NIH grants

NIH awards 35

Annual award amounts. Total $15.8M.

May 27, 2026 NIH award 5R43AI189041-02 FY2026: $277,962 awarded for that fiscal year; activity R43 (SBIR); PI DOLLERY, STEPHEN JEFFREY; recipient as written: BIOLOGICAL MIMETICS, INC., FREDERICK, MD. A Subunit Vaccine Against Aci source ↗
Aug 6, 2025 NIH award 5R43AI179513-02 FY2025: $291,139 awarded for that fiscal year; activity R43 (SBIR); PI TOBIN, GREGORY JOHN; recipient as written: BIOLOGICAL MIMETICS, INC., FREDERICK, MD. An instrument-free malaria diagnos source ↗
2025 NIH contract (government contract; not a grant and not an investment round) 75N93025C00031-0-9999-1 FY2025: $1,498,641 awarded for that fiscal year; activity N43 (OTHER_NIH); PI TOBIN, GREGORY JOHN; recipient as written: BIOLOGICAL MIMETICS, INC., FREDERICK, M source ↗
Dec 23, 2024 NIH award 1R43AI189041-01 FY2025: $288,360 awarded for that fiscal year; activity R43 (SBIR); PI DOLLERY, STEPHEN JEFFREY; recipient as written: BIOLOGICAL MIMETICS, INC., FREDERICK, MD. A Subunit Vaccine Against Aci source ↗
Aug 15, 2024 NIH award 5R43AI174497-02 FY2024: $296,442 awarded for that fiscal year; activity R43 (SBIR); PI DOLLERY, STEPHEN JEFFREY; recipient as written: BIOLOGICAL MIMETICS, INC., FREDERICK, MD. Development of a Staph Aureus source ↗
May 30, 2024 NIH award 1R43AI179513-01A1 FY2024: $297,761 awarded for that fiscal year; activity R43 (SBIR); PI TOBIN, GREGORY JOHN; recipient as written: BIOLOGICAL MIMETICS, INC., FREDERICK, MD. An instrument-free malaria diagn source ↗
May 13, 2024 NIH award 5R44AI120260-06 FY2024: $917,012 awarded for that fiscal year; activity R44 (SBIR); PI TOBIN, GREGORY JOHN; recipient as written: BIOLOGICAL MIMETICS, INC., FREDERICK, MD. Nonclinical Development of an Impr source ↗
Sep 20, 2023 NIH award 1R43AI174497-01A1 FY2023: $296,442 awarded for that fiscal year; activity R43 (SBIR); PI DOLLERY, STEPHEN JEFFREY; recipient as written: BIOLOGICAL MIMETICS, INC., FREDERICK, MD. Development of a Staph Aure source ↗
May 26, 2023 NIH award 5R44AI120260-05 FY2023: $976,542 awarded for that fiscal year; activity R44 (SBIR); PI TOBIN, GREGORY JOHN; recipient as written: BIOLOGICAL MIMETICS, INC., FREDERICK, MD. Nonclinical Development of an Impr source ↗
2023 NIH contract (government contract; not a grant and not an investment round) 75N93023C00056-0-9999-1 FY2023: $299,820 awarded for that fiscal year; activity N43 (OTHER_NIH); PI TOBIN, GREGORY; recipient as written: BIOLOGICAL MIMETICS, INC., FREDERICK, MD. CRIS source ↗
Jun 22, 2022 NIH award 2R44AI120260-04A1 FY2022: $990,662 awarded for that fiscal year; activity R44 (SBIR); PI TOBIN, GREGORY JOHN; recipient as written: BIOLOGICAL MIMETICS, INC., FREDERICK, MD. Nonclinical Development of an Im source ↗
Jun 3, 2021 NIH award 5R43AI152652-02 FY2021: $299,218 awarded for that fiscal year; activity R43 (SBIR); PI MACLEOD, DAVID A; recipient as written: BIOLOGICAL MIMETICS, INC., FREDERICK, MD. Development of a Universal Influenza source ↗
Jul 4, 2020 NIH award 1R43AI152652-01A1 FY2020: $299,218 awarded for that fiscal year; activity R43 (SBIR); PI MACLEOD, DAVID A; recipient as written: BIOLOGICAL MIMETICS, INC., FREDERICK, MD. Development of a Universal Influenz source ↗
Apr 5, 2019 NIH award 1R43AI145457-01 FY2019: $224,957 awarded for that fiscal year; activity R43 (SBIR); PI DOLLERY, STEPHEN JEFFREY; recipient as written: BIOLOGICAL MIMETICS, INC., FREDERICK, MD. Whole-Cell Vaccine Developmen source ↗
Dec 25, 2018 NIH award 1R43AI142830-01 FY2019: $224,958 awarded for that fiscal year; activity R43 (SBIR); PI TOBIN, GREGORY JOHN; recipient as written: BIOLOGICAL MIMETICS, INC., FREDERICK, MD. Development of a cross-protective source ↗
Sep 11, 2018 NIH award 1R43AI140809-01 FY2018: $299,372 awarded for that fiscal year; activity R43 (SBIR); PI TOBIN, GREGORY JOHN; recipient as written: BIOLOGICAL MIMETICS, INC., FREDERICK, MD. Manganese-peptide Countermeasures source ↗
Jan 17, 2018 NIH award 1R43AI122411-01A1 FY2018: $224,956 awarded for that fiscal year; activity R43 (SBIR); PI TOBIN, GREGORY JOHN; recipient as written: BIOLOGICAL MIMETICS, INC., FREDERICK, MD. Improved RSV F Vaccine Candidate source ↗
Jan 9, 2018 NIH award 5R44AI120260-03 FY2018: $723,136 awarded for that fiscal year; activity R44 (SBIR); PI TOBIN, GREGORY JOHN; recipient as written: BIOLOGICAL MIMETICS, INC., FREDERICK, MD. Development of an improved, low-co source ↗
Feb 16, 2017 NIH award 2R44AI120260-02 FY2017: $743,104 awarded for that fiscal year; activity R44 (SBIR); PI TOBIN, GREGORY JOHN; recipient as written: BIOLOGICAL MIMETICS, INC., FREDERICK, MD. Development of an improved, low-co source ↗
May 26, 2016 NIH award 5R44AI085683-05 FY2016: $999,998 awarded for that fiscal year; activity R44 (SBIR); PI TOBIN, GREGORY JOHN; recipient as written: BIOLOGICAL MIMETICS, INC., FREDERICK, MD. Development of the first HRV vacci source ↗
Jun 5, 2015 NIH award 5R44AI085683-04 FY2015: $999,998 awarded for that fiscal year; activity R44 (SBIR); PI TOBIN, GREGORY JOHN; recipient as written: BIOLOGICAL MIMETICS, INC., FREDERICK, MD. Development of the first HRV vacci source ↗
May 15, 2015 NIH award 1R43AI120260-01 FY2015: $224,887 awarded for that fiscal year; activity R43 (SBIR); PI TOBIN, GREGORY JOHN; recipient as written: BIOLOGICAL MIMETICS, INC., FREDERICK, MD. Development of a New Low-Cost Poli source ↗
May 22, 2014 NIH award 2R44AI085683-03A1 FY2014: $923,094 awarded for that fiscal year; activity R44 (SBIR); PI TOBIN, GREGORY JOHN; recipient as written: BIOLOGICAL MIMETICS, INC., FREDERICK, MD. Development of the first HRV vac source ↗
Jun 30, 2011 NIH award 5R43AI085683-02 FY2011: $299,164 awarded for that fiscal year; activity R43 (SBIR); PI TOBIN, GREGORY JOHN; recipient as written: BIOLOGICAL MIMETICS, INC., FREDERICK, MD. Development of a novel human rhino source ↗
Jul 5, 2010 NIH award 1R43AI085683-01A1 FY2010: $298,345 awarded for that fiscal year; activity R43 (SBIR); PI TOBIN, GREGORY JOHN; recipient as written: BIOLOGICAL MIMETICS, INC., FREDERICK, MD. Development of a novel human rhi source ↗
Apr 1, 2006 NIH award 5R21AI065234-02 FY2006: $281,232 awarded for that fiscal year; activity R21 (OTHER_NIH); PI LIN, GEORGE; recipient as written: BIOLOGICAL MIMETICS, INC., FREDERICK, MD. HIV-2 Env Variable Loop Deletions as source ↗
Mar 24, 2005 NIH award 1R21AI065234-01 FY2005: $288,000 awarded for that fiscal year; activity R21 (OTHER_NIH); PI LIN, GEORGE; recipient as written: BIOLOGICAL MIMETICS, INC., FREDERICK, MD. HIV-2 Env Variable Loop Deletions as source ↗
Jul 6, 2004 NIH award 5R43AI055221-02 FY2004: $299,999 awarded for that fiscal year; activity R43 (SBIR); PI NARA, PETER LLOYD; recipient as written: BIOLOGICAL MIMETICS, INC., FREDERICK, MD. Immune Dampening the OMPs of non-typ source ↗
Jul 10, 2003 NIH award 1R43AI055221-01 FY2003: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI NARA, PETER LLOYD; recipient as written: BIOLOGICAL MIMETICS, INC., FREDERICK, MD. Immune Dampening the OMPs of non-typ source ↗
Aug 27, 2001 NIH award 1R43AI048972-01A1 FY2001: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI NARA, PETER LLOYD; recipient as written: BIOLOGICAL MIMETICS, INC., FREDERICK, MD. Masking the GH-loop: model for hum source ↗

Funding and NIH signals

NIH award NIH awarded $278K (SBIR Phase I 5R43AI189041-02, continuation, notice May 27, 2026). NIH RePORTER 5R43AI189041-02 (May 27, 2026)
Evidence (1 event)
- May 27, 2026 · NIH RePORTER 5R43AI189041-02
  Organization: BIOLOGICAL MIMETICS, INC.; City/State: FREDERICK, MD; Project number: 5R43AI189041-02; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-05-27; FY total cost (award amount): 277962; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: A Subunit Vaccine Against Acinetobacter Baumannii; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals